|
US4625014A
(en)
*
|
1984-07-10 |
1986-11-25 |
Dana-Farber Cancer Institute, Inc. |
Cell-delivery agent
|
|
US4659839A
(en)
|
1984-10-10 |
1987-04-21 |
Mallinckrodt, Inc. |
Coupling agents for radiolabeled antibody fragments
|
|
ATE145337T1
(de)
*
|
1988-05-02 |
1996-12-15 |
Phanos Tech Inc |
Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
|
|
US5126129A
(en)
|
1988-05-23 |
1992-06-30 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services |
Cancer therapy using interleukin-2 and flavone compounds
|
|
AU637800B2
(en)
|
1989-08-31 |
1993-06-10 |
City Of Hope |
Chimeric dna-rna catalytic sequences
|
|
US5290551A
(en)
|
1990-05-08 |
1994-03-01 |
Thomas Jefferson University |
Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten
|
|
ES2061416T3
(es)
|
1990-10-12 |
1997-03-01 |
Max Planck Gesellschaft |
Ribozimas modificadas.
|
|
DE4216134A1
(de)
|
1991-06-20 |
1992-12-24 |
Europ Lab Molekularbiolog |
Synthetische katalytische oligonukleotidstrukturen
|
|
US5652094A
(en)
|
1992-01-31 |
1997-07-29 |
University Of Montreal |
Nucleozymes
|
|
US20030206887A1
(en)
|
1992-05-14 |
2003-11-06 |
David Morrissey |
RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA)
|
|
US5437951A
(en)
|
1992-09-03 |
1995-08-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Self-assembling recombinant papillomavirus capsid proteins
|
|
US5478556A
(en)
|
1994-02-28 |
1995-12-26 |
Elliott; Robert L. |
Vaccination of cancer patients using tumor-associated antigens mixed with interleukin-2 and granulocyte-macrophage colony stimulating factor
|
|
US5716824A
(en)
|
1995-04-20 |
1998-02-10 |
Ribozyme Pharmaceuticals, Inc. |
2'-O-alkylthioalkyl and 2-C-alkylthioalkyl-containing enzymatic nucleic acids (ribozymes)
|
|
US5783169A
(en)
|
1995-07-26 |
1998-07-21 |
Brookhaven Science Associates Llc |
Rigid bifunctional chelating agents
|
|
WO1997026270A2
(en)
|
1996-01-16 |
1997-07-24 |
Ribozyme Pharmaceuticals, Inc. |
Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
|
|
IT1283218B1
(it)
*
|
1996-03-08 |
1998-04-16 |
Bracco Spa |
Polichelanti, loro complessi con ioni metallici, loro preparazione e loro usi
|
|
JP2000515741A
(ja)
|
1996-07-17 |
2000-11-28 |
アメリカ合衆国 |
感染性パピローマウイルス偽ウイルス粒子
|
|
US6180389B1
(en)
|
1997-01-03 |
2001-01-30 |
The Research And Development Institute, Inc. |
Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules
|
|
US6852703B1
(en)
|
1997-06-04 |
2005-02-08 |
Oxford Biomedica (Uk) Limited |
Tumor targeted vector
|
|
EP1015561B1
(en)
|
1997-09-05 |
2006-07-19 |
Medimmune, Inc. |
In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps)
|
|
US7351533B2
(en)
|
1997-09-05 |
2008-04-01 |
Medimmune, Inc. |
In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
|
|
FR2768749A1
(fr)
|
1997-09-22 |
1999-03-26 |
Inst Nat Sante Rech Med |
Virus artificiels derives de papillomavirus, et leurs utilisations, notamment en therapie genique
|
|
AU5298699A
(en)
|
1998-08-13 |
2000-03-06 |
Johnson & Johnson Research Pty. Limited |
Dnazymes and methods for treating hpv-related disorders
|
|
US6991795B1
(en)
|
1998-08-14 |
2006-01-31 |
Merck & Co., Inc. |
Protein delivery system using human papillomavirus virus-like particles
|
|
US20050112141A1
(en)
|
2000-08-30 |
2005-05-26 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
|
US20040146531A1
(en)
|
1999-09-30 |
2004-07-29 |
Active Biotech Ab |
Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cells
|
|
WO2001055393A2
(en)
|
2000-01-28 |
2001-08-02 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
|
|
CN1114690C
(zh)
|
2001-05-15 |
2003-07-16 |
乔良 |
乳头瘤假病毒及其制备方法
|
|
JP2004535813A
(ja)
|
2001-07-17 |
2004-12-02 |
ミルナー，アン，ジョセフィーヌ |
遺伝子発現のサイレンシング
|
|
US20030129583A1
(en)
*
|
2002-01-08 |
2003-07-10 |
Martin William John |
Therapy of stealth virus associated cancers and other conditions using light
|
|
EP1467760A2
(en)
*
|
2002-01-23 |
2004-10-20 |
Light Sciences Corporation |
Systems and methods for photodynamic therapy
|
|
AU2003272187A1
(en)
|
2002-02-01 |
2004-01-06 |
Montana State University |
Novel nanoparticles and use thereof
|
|
US20040121465A1
(en)
|
2002-02-14 |
2004-06-24 |
Novavax, Inc. |
Optimization of gene sequences of virus-like particles for expression in insect cells
|
|
JP2003286189A
(ja)
|
2002-03-29 |
2003-10-07 |
Japan Science & Technology Corp |
中空ナノ粒子を形成するタンパク質に疾患治療用の細胞導入物質を融合させた薬剤
|
|
JP4212921B2
(ja)
|
2002-03-29 |
2009-01-21 |
独立行政法人科学技術振興機構 |
抗体を提示するタンパク質中空ナノ粒子を用いる治療薬剤およびタンパク質中空ナノ粒子
|
|
AU2003239531A1
(en)
|
2002-05-17 |
2003-12-02 |
Montana State University |
Protein cages for the delivery of medical imaging and therapy
|
|
BR0311995A
(pt)
|
2002-06-20 |
2005-04-05 |
Cytos Biotechnology Ag |
Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso
|
|
KR100632073B1
(ko)
|
2002-06-28 |
2006-10-04 |
도꾸리쯔교세이호징 가가꾸 기쥬쯔 신꼬 기꼬 |
시스테인 잔기를 변형한 단백질로 이루어지는 중공 나노입자 및 이를 이용한 약제
|
|
JP2004261002A
(ja)
|
2003-01-08 |
2004-09-24 |
Tsutomu Suzuki |
ｓｉＲＮＡの製造方法
|
|
WO2005051431A1
(en)
|
2003-11-25 |
2005-06-09 |
The University Of York |
Colloidal delivery system for biological therapeutic agents
|
|
US7928290B2
(en)
|
2004-02-27 |
2011-04-19 |
Dow Agrosciences Llc |
Viral capsid fusion peptide expressing plant cells
|
|
WO2006093967A2
(en)
*
|
2005-02-28 |
2006-09-08 |
The Scripps Research Institute |
Compositions and methods for targeting or imaging a tissue in a vertebrate subject
|
|
EP1891216B1
(en)
|
2005-05-25 |
2012-02-22 |
The University Of York |
Hybrid interfering rna
|
|
GB2426687A
(en)
|
2005-05-26 |
2006-12-06 |
Jason Kershaw |
Inter-engaging fasteners
|
|
JP5077914B2
(ja)
|
2005-08-05 |
2012-11-21 |
シンジーテック株式会社 |
電子写真装置用ポリウレタン部材
|
|
US20070059746A1
(en)
|
2005-09-14 |
2007-03-15 |
Japan Science And Technology Agency |
Substance carrier using hollow nanoparticle of hepatitis B virus protein and liposome, and method of introducing substance into cell
|
|
US20070258889A1
(en)
|
2005-11-09 |
2007-11-08 |
Montana State University |
Novel nanoparticles and use thereof
|
|
US20110104051A1
(en)
|
2006-03-27 |
2011-05-05 |
The Regents Of The University Of California |
Chemically Modified Viral Capsids as Targeted Delivery Vectors for Diagnostic and Therapeutic Agents
|
|
US7700541B2
(en)
|
2006-04-06 |
2010-04-20 |
Nitto Denko Corporation |
Biodegradable cationic polymers
|
|
CN100415859C
(zh)
|
2006-07-28 |
2008-09-03 |
上海应用技术学院 |
薰衣草纳米精油的制备方法
|
|
US20100003326A1
(en)
|
2006-08-01 |
2010-01-07 |
Dolphys Technologies B.V. |
Drug delivery device comprising a pharmaceutically or biologically active component and an infrared absorbing compound
|
|
KR100962301B1
(ko)
|
2006-11-03 |
2010-06-11 |
재단법인서울대학교산학협력재단 |
자궁경부암을 위한 치료용 조성물
|
|
US20090035389A1
(en)
|
2007-02-23 |
2009-02-05 |
Specigen Inc. |
Targeted protein cages
|
|
US20130136689A1
(en)
*
|
2007-06-05 |
2013-05-30 |
Christian Rohlff |
Proteins
|
|
PT2145189E
(pt)
*
|
2007-05-08 |
2016-06-16 |
Us Health |
Pseudovírus de papilomavírus para deteção e terapêutica de tumores
|
|
WO2009046738A1
(en)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
|
|
WO2009106999A2
(en)
|
2008-02-28 |
2009-09-03 |
Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts |
Hollow nanoparticles and uses thereof
|
|
JP2012500855A
(ja)
|
2008-08-25 |
2012-01-12 |
アンプリミューン、インコーポレーテッド |
Ｐｄ−１アンタゴニストおよび感染性疾患を処置するための方法
|
|
US20120015899A1
(en)
|
2008-10-25 |
2012-01-19 |
Plant Bioscience, Limited |
Modified plant virus particles and uses therefor
|
|
CN107252489A
(zh)
*
|
2009-04-13 |
2017-10-17 |
法国健康和医学研究院 |
Hpv颗粒及其用途
|
|
CN102573910B
(zh)
*
|
2009-06-12 |
2015-08-26 |
鹿特丹伊拉斯谟大学医疗中心 |
用于癌症光动力学治疗的靶向纳米光药物
|
|
US8993715B2
(en)
|
2009-07-06 |
2015-03-31 |
Canon Kabushiki Kaisha |
Labeled protein and method for obtaining the same
|
|
WO2011039646A2
(en)
|
2009-09-30 |
2011-04-07 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Papilloma virus -like particles for targeted gene delivery
|
|
US20120207840A1
(en)
|
2011-02-10 |
2012-08-16 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer
|
|
US20130071414A1
(en)
|
2011-04-27 |
2013-03-21 |
Gianpietro Dotti |
Engineered cd19-specific t lymphocytes that coexpress il-15 and an inducible caspase-9 based suicide gene for the treatment of b-cell malignancies
|
|
WO2013009717A1
(en)
|
2011-07-10 |
2013-01-17 |
Elisabet De Los Pinos |
Virion derived protein nanoparticles for delivering diagnostic or therapeutic agents for the treatment of skin-related diseases
|
|
JP2014231477A
(ja)
|
2011-09-21 |
2014-12-11 |
シャープ株式会社 |
アルコキシ基を有する遷移金属錯体、及びこれを用いた有機発光素子、色変換発光素子、光変換発光素子、有機レーザーダイオード発光素子、色素レーザー、表示装置、照明装置並びに電子機器
|
|
US20130115247A1
(en)
|
2011-11-05 |
2013-05-09 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy
|
|
US20130116408A1
(en)
*
|
2011-11-05 |
2013-05-09 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy
|
|
US9771397B2
(en)
*
|
2011-12-01 |
2017-09-26 |
University Of Cape Town |
HPV chimaeric particle
|
|
WO2013119877A1
(en)
*
|
2012-02-07 |
2013-08-15 |
Aura Biosciences, Inc. |
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
|
|
MX367730B
(es)
|
2012-09-04 |
2019-09-04 |
Cellectis |
Receptor de antigeno quimerico multi-cadena y usos del mismo.
|
|
DK2986311T3
(en)
|
2013-04-18 |
2019-02-25 |
Tilt Biotherapeutics Oy |
IMPROVED ADOPTIVE CELL THERAPY
|
|
US20160024469A1
(en)
|
2013-07-29 |
2016-01-28 |
Allan Yang Wu |
Non-conventional Cellular Based Immunotherapy
|
|
EP3046583B1
(en)
|
2013-09-18 |
2019-02-13 |
Aura Biosciences, Inc. |
Virus-like particle conjugates for treatment of tumors
|
|
MX373687B
(es)
|
2013-11-21 |
2020-07-07 |
Ucl Business Ltd |
Célula natural (nk)
|
|
ES2792849T3
(es)
|
2014-02-10 |
2020-11-12 |
Univ Emory |
Expresión de polipéptido químico con receptores de linfocitos variables en células inmunes y usos para tratar el cáncer
|
|
US20170335281A1
(en)
|
2014-03-15 |
2017-11-23 |
Novartis Ag |
Treatment of cancer using chimeric antigen receptor
|
|
GB201503776D0
(en)
|
2015-03-05 |
2015-04-22 |
Pci Biotech As |
Compound and method
|
|
US11154620B2
(en)
|
2015-08-18 |
2021-10-26 |
Rakuten Medical, Inc. |
Compositions, combinations and related methods for photoimmunotherapy
|
|
WO2017075399A1
(en)
|
2015-10-30 |
2017-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Targeted cancer therapy
|
|
JP2018532801A
(ja)
|
2015-10-30 |
2018-11-08 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
標的化がん療法
|
|
IL269986B2
(en)
|
2017-04-12 |
2024-06-01 |
Aura Biosciences Inc |
Targeted combination therapy
|